This compound is a macrolide derivative used as a reference standard for the identification and quantification of the impurity designated as Clarithromycin EP Impurity P in pharmaceutical quality control.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 123967-58-8
Clarithromycine
active pharmaceutical ingredient
N-Demethyl-N-formyl Clarithromycin
Clarithromycin impurity
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-((4-Dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy)-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
Clarithromycin intermediate reference standard
N-Desmethylclarithromycin
active pharmaceutical ingredient
Acetamidine monohydrochloride
pharmaceutical intermediate
Chlorure de méthanesulfonyle
Chemical intermediate for drug synthesis
(3aR,4R,5R,6aS)-5-(tert-butyldimethylsilyloxy)-4-((R,E)-3-(tert-butyldimethylsilyloxy)-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one
pharmaceutical intermediate
1-AMINO-4,4-DIFLUOROCYCLOHEXANECARBOXYLIC ACID
Pharmaceutical intermediate for drug synthesis
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2R,4R,5S,6S)-4,5-dimethoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
GABUBURUMNNRLM-AUALEGHESA-N
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)OC)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O